OTC Supplement (US)Oral / SubQ · NAD+ Precursor

NMN

Nicotinamide Mononucleotide — NAD+ Precursor

Half-life
~15 min (plasma NMN); NAD+ elevated for hours
Route
Oral or SubQ
Typical dose
250–1000 mg/day
Reconstitutable
No — oral capsule (or SubQ solution)

What is NMN?

NMN (Nicotinamide Mononucleotide) is a direct precursor to NAD+, sitting one step upstream in the biosynthetic pathway. Unlike NR (nicotinamide riboside), NMN can be taken up by cells directly through a dedicated transporter (Slc12a8) in some tissues, bypassing the phosphorylation step required for NR. NMN supplementation reliably raises blood and tissue NAD+ levels and has become one of the most researched longevity supplements.

NMN is converted to NAD+ through the Nmnat enzymes. The resulting NAD+ elevation activates sirtuins (SIRT1-7) — NAD+-dependent deacylases that regulate gene expression, DNA repair, mitochondrial biogenesis, and cellular stress resistance. It also activates PARPs for DNA repair and CD38 for immune signaling. The longevity benefits are proposed to come from restoring the NAD+ levels of youth that decline approximately 50% by age 60.

Research Evidence

SilverNAD+ Elevation (Human)

Multiple human trials confirm NMN supplementation raises blood NAD+ levels dose-dependently. The Washington University trial showed NMN improved insulin sensitivity and muscle NAD+ in prediabetic women.

SilverPhysical Performance

A Japanese trial showed NMN improved physical performance markers in older men vs placebo. Muscle function and NAD+ metabolism improved.

BronzeAnti-aging (General)

The longevity narrative for NMN is compelling based on animal data and the NAD+ decline with aging. Human longevity trial data is still emerging. David Sinclair's research at Harvard has been influential in popularizing NMN.

Evidence grades: Gold = RCT human data · Silver = consistent animal/human data · Bronze = limited or preliminary

Dosing Protocols

Standard dose
250–500 mg/day oral
Most human trials use 250-500mg. Some protocols use up to 1g/day. Take in the morning — NAD+ is involved in circadian rhythm.
SubQ option
50–100 mg SubQ
Some biohackers inject NMN subcutaneously for higher bioavailability, though oral absorption is generally considered adequate.
Stack
Resveratrol / Pterostilbene
SIRT1 activators (resveratrol, pterostilbene) are commonly stacked with NMN — the NMN provides the NAD+ fuel and the sirtuin activators increase SIRT1 activity.

Reconstitution / Preparation

This compound does not require reconstitution — it is available as an oral or pre-mixed formulation.

Frequently Asked Questions

Is NMN or NR better?

Both raise NAD+ effectively. NMN has a dedicated cellular transporter in some tissues (allowing direct uptake), while NR must be phosphorylated first. NMN is generally considered to have faster and more direct conversion to NAD+ in certain tissues. NR has a longer human trial record. Most longevity researchers who use both suggest they are largely interchangeable, with personal preference and cost being the main differentiators.

Does NMN extend human lifespan?

Human longevity trial data does not yet exist. Animal data is compelling — mice on NMN show improved muscle function, metabolic health, and some longevity markers. The human trials published so far demonstrate safety, NAD+ elevation, and improvements in metabolic and physical function markers. Whether this translates to lifespan extension in humans is unknown.

References

  1. [1]Yoshino M, Miao W, Chin SH, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229.
  2. [2]Igarashi M, Miura M, Williams E, et al. NAD+ supplementation rejuvenates aged gut adult stem cells. Aging Cell. 2019;18(3):e12935.
Disclaimer: This profile is for informational and research purposes only. Not medical advice. Always consult a licensed healthcare provider before using any compound.

This profile was prepared using AI-assisted research synthesis. Citations are provided where applicable — verify with primary sources before clinical application.

Share this article